Shared on26 Sep 25Fair value Decreased 2.19%
Analysts have trimmed Azelis Group’s price target to €19.13, citing weaker Q2 earnings, a more conservative sector outlook, and increased market risk, partially offset by sustained strength in specialty testing. Analyst Commentary Reduced earnings estimates following a weaker-than-expected Q2 report.
Shared on05 Sep 25
Analysts have trimmed their earnings estimates and near-term growth outlook for Azelis Group amid sector challenges and softer fundamentals, resulting in a stable consensus price target of €19.56. Analyst Commentary Reduced earnings estimates following a weaker-than-expected Q2 report.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 1.31%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25Fair value Decreased 0.24%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25Fair value Decreased 0.67%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Increased 20%
AnalystConsensusTarget has increased revenue growth from 5.8% to 6.4%.